This ICR for the
Wilms Tumor Study is approved for two years to determine if further
research is necessary. ASTDR will carefully examine confounding
factors and determine if there are adequate controls. In additon,
ASTDR should make sure future research plans go through external
peer review by disinterested parties. OMB stands ready to help
develop and review the methods and procedures for future research
plans to ensure the results have practical utility as required by
the Paperwork Reduction Act.
Inventory as of this Action
Requested
Previously Approved
09/30/1997
09/30/1997
3,637
0
0
587
0
0
0
0
0
Wilms Tumor, as a type of renal
cancor, is among the Priority Health Condition identified by the
Agency for Toxic Substances and Disease Registry to assist in
directing its applied researh programs examining the relationship
between hazardous substance exposures and health impacts. Results
of other Wilms Tumor studies have linked environmental and
occupational hazardous substances exposures and these forms of
cancer. This proposed national study, focusing on cases identified
through the National Wilms Tumor Study Group, and including a
randomly- selected control group, is designed to examine the
potential.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.